Bonus BioGroup Ltd. (BBIXF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.52 Million ILS | 26.29% |
| 2022 | -38.7 Million ILS | 57.03% |
| 2021 | -90.07 Million ILS | -309.05% |
| 2020 | -22.02 Million ILS | 0.98% |
| 2019 | -22.24 Million ILS | -18.71% |
| 2018 | -18.73 Million ILS | 7.24% |
| 2017 | -20.19 Million ILS | -25.87% |
| 2016 | -16.04 Million ILS | -19.22% |
| 2015 | -13.45 Million ILS | -20.09% |
| 2014 | -11.2 Million ILS | -15.52% |
| 2013 | -9.7 Million ILS | 46.02% |
| 2012 | -17.97 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -7.05 Million ILS | 10.98% |
| 2024 Q1 | -7.92 Million ILS | -5.61% |
| 2023 Q1 | -7.61 Million ILS | 23.89% |
| 2023 Q4 | -7.5 Million ILS | -11.83% |
| 2023 Q3 | -6.7 Million ILS | -0.12% |
| 2023 FY | -28.52 Million ILS | 26.29% |
| 2023 Q2 | -6.7 Million ILS | 12.01% |
| 2022 Q3 | -16.1 Million ILS | -204.18% |
| 2022 Q1 | -7.3 Million ILS | 54.37% |
| 2022 Q2 | -5.29 Million ILS | 27.53% |
| 2022 FY | -38.7 Million ILS | 57.03% |
| 2022 Q4 | -10 Million ILS | 37.85% |
| 2021 Q3 | -11.52 Million ILS | 34.44% |
| 2021 Q4 | -16 Million ILS | -38.85% |
| 2021 FY | -90.07 Million ILS | -309.05% |
| 2021 Q1 | -44.95 Million ILS | -501.44% |
| 2021 Q2 | -17.58 Million ILS | 60.89% |
| 2020 Q2 | -4.97 Million ILS | 20.57% |
| 2020 Q1 | -6.26 Million ILS | -33.52% |
| 2020 Q3 | -3.3 Million ILS | 33.63% |
| 2020 FY | -22.02 Million ILS | 0.98% |
| 2020 Q4 | -7.47 Million ILS | -126.31% |
| 2019 Q3 | -4.72 Million ILS | 9.91% |
| 2019 Q1 | -7.58 Million ILS | -37.19% |
| 2019 FY | -22.24 Million ILS | -18.71% |
| 2019 Q4 | -4.69 Million ILS | 0.57% |
| 2019 Q2 | -5.23 Million ILS | 30.96% |
| 2018 Q1 | -5.01 Million ILS | -35.75% |
| 2018 Q4 | -5.53 Million ILS | -30.57% |
| 2018 FY | -18.73 Million ILS | 7.24% |
| 2018 Q3 | -4.23 Million ILS | -7.19% |
| 2018 Q2 | -3.95 Million ILS | 21.21% |
| 2017 FY | -20.19 Million ILS | -25.87% |
| 2017 Q3 | -9.35 Million ILS | -159.99% |
| 2017 Q2 | -3.59 Million ILS | -1.24% |
| 2017 Q4 | -3.69 Million ILS | 60.49% |
| 2017 Q1 | -3.55 Million ILS | -7.05% |
| 2016 Q1 | -3.2 Million ILS | 27.73% |
| 2016 FY | -16.04 Million ILS | -19.22% |
| 2016 Q2 | -3.2 Million ILS | 0.12% |
| 2016 Q4 | -3.31 Million ILS | 47.49% |
| 2016 Q3 | -6.32 Million ILS | -97.47% |
| 2015 Q3 | -3.48 Million ILS | -18.24% |
| 2015 Q2 | -2.94 Million ILS | -13.95% |
| 2015 Q1 | -2.58 Million ILS | 10.97% |
| 2015 FY | -13.45 Million ILS | -20.09% |
| 2015 Q4 | -4.43 Million ILS | -27.19% |
| 2014 Q2 | -2.95 Million ILS | 7.19% |
| 2014 FY | -11.2 Million ILS | -15.52% |
| 2014 Q1 | -3.18 Million ILS | 1.85% |
| 2014 Q3 | -2.15 Million ILS | 27.05% |
| 2014 Q4 | -2.9 Million ILS | -34.77% |
| 2013 FY | -9.7 Million ILS | 46.02% |
| 2013 Q1 | -2.12 Million ILS | 0.0% |
| 2013 Q2 | -1.86 Million ILS | 11.97% |
| 2013 Q3 | -2.46 Million ILS | -31.96% |
| 2013 Q4 | -3.24 Million ILS | -31.68% |
| 2012 FY | -17.97 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 153.85% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -308.559% |
| CSL Limited | 2.64 Billion USD | 101.08% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 143.801% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2887.374% |
| BioStem Technologies, Inc. | -8.48 Million USD | -236.309% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -647.028% |
| Qrons Inc. | -789.34 Thousand USD | -3514.253% |
| Nascent Biotech, Inc. | -2.08 Million USD | -1266.54% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 54.426% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -260.985% |
| Skye Bioscience, Inc. | -37.64 Million USD | 24.215% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -6766.532% |
| Rebus Holdings, Inc. | -1.02 Million USD | -2696.961% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -79.751% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -2036.314% |
| Genscript Biotech Corporation | -95.47 Million USD | 70.12% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -4411.177% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 61.943% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -333.828% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -10334.818% |
| SQZ Biotechnologies Company | -79.46 Million USD | 64.098% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -886.346% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1467.073% |
| Mesoblast Limited | -87.95 Million USD | 67.564% |
| Marizyme, Inc. | -65.34 Million USD | 56.342% |
| Genus plc | 7.9 Million USD | 461.127% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -161.932% |
| Pharming Group N.V. | -10.54 Million USD | -170.468% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -1214.813% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -668.927% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -222.58% |
| ContraFect Corporation | -65.15 Million USD | 56.212% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -483.885% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1551.505% |
| IMV Inc. | -36.48 Million USD | 21.808% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -253.972% |
| MultiCell Technologies, Inc. | -380.07 USD | -7506148.849% |
| ONE Bio Corp. | 8.67 Million USD | 428.803% |
| Accustem Sciences Inc. | -3.74 Million USD | -661.501% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 44.81% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -2151.459% |
| Q BioMed Inc. | -2.05 Million USD | -1290.239% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -664.238% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -1098.259% |
| Biomind Labs Inc. | -1.21 Million USD | -2249.383% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 52.233% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -819.766% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1363.589% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -190398.13% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -390.42% |
| GB Sciences, Inc. | -1.36 Million USD | -1995.137% |
| Alpha Cognition Inc. | -13.77 Million USD | -107.144% |
| HST Global, Inc. | -146.21 Thousand USD | -19412.345% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1525.796% |
| Halberd Corporation | -79.67 Thousand USD | -35706.265% |
| Enzolytics Inc. | -2.17 Million USD | -1210.574% |
| Agentix Corp. | -1.37 Million USD | -1976.028% |
| Resverlogix Corp. | -3.61 Million USD | -690.277% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -799.561% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 90.331% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 29211.224% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 511.995% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -618.073% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -842.754% |
| AVAX Technologies, Inc. | -6.41 Million USD | -344.817% |
| Zenith Capital Corp. | -10.59 Million USD | -169.243% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -122647.612% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -588.12% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -47101.708% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1322.811% |
| Kadimastem Ltd | -3.3 Million USD | -762.581% |
| Helix BioMedix, Inc. | -1.05 Million USD | -2601.464% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -6363.753% |
| LadRx Corporation | 400.44 Thousand USD | 7224.36% |
| Cell Source, Inc. | -5.32 Million USD | -436.137% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2887.374% |
| NovAccess Global Inc. | -4.76 Million USD | -498.194% |
| Affymax, Inc. | -14.42 Million USD | -97.788% |
| Itoco Inc. | -1.86 Million USD | -1426.435% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -542.178% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1609.347% |
| Mobile Lads Corp. | -2.26 Million USD | -1160.509% |
| CytoDyn Inc. | -49.84 Million USD | 42.76% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -35997.579% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -12405.753% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2930.071% |
| SYBLEU INC | -180.3 Thousand USD | -15722.722% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1668.98% |
| International Stem Cell Corporation | -131 Thousand USD | -21677.863% |
| Bioxytran, Inc. | -4.28 Million USD | -566.565% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -52466.701% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -1027.518% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 40.654% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -1249.527% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -3553.41% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -800.537% |
| Neutra Corp. | -233.46 Thousand USD | -12119.819% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -40.599% |
| PureTech Health plc | -65.69 Million USD | 56.575% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -34.15% |
| IXICO plc | -1.17 Million USD | -2321.817% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -187.388% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 50.061% |
| CSL Limited | 2.64 Billion USD | 101.08% |
| Cellectis S.A. | -103.17 Million USD | 72.349% |